Home/Stocks/INMB

INMB

USD

INmune Bio Inc. Common stock

$1.720-0.050 (-2.825%)

Real-time Price

Healthcare

Biotechnology

United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics

Company Fundamentals

Trading Stats

Market Metrics

Open

$1.770

High

$1.790

Low

$1.710

Volume

0.26M

Company Fundamentals

Market Cap

45.7M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.61M

Exchange

NCM

Currency

USD

52-Week Range

Low $1.71Current $1.720High $11.64

Related News

Oct 30, 2025 · 08:05 PM

GlobeNewswire

INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update

BOCA RATON, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient's innate

Oct 23, 2025 · 11:00 AM

GlobeNewswire

INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025

Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, Oct. 23, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) (the "Company"), INmune Bio Inc. (NASDAQ:INMB), a

Oct 14, 2025 · 11:00 AM

GlobeNewswire

INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025

Boca Raton, FL, Oct. 14, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ:INMB), a clinical-stage inflammation and immunology company, today announces that David Moss, Chief Executive Officer will participate in a